Skip to main content
Caplight Logo









Ovelle Bio Corp.

Ovelle Bio Corp.

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://ovelle.bio/

Last Round

Seed Round

Jun 10, 2026

Total Funding Raised

$667,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Ovelle Bio Corp. is a biotechnology company developing in vitro gametogenesis (IVG), a revolutionary approach to create eggs from somatic cells to provide a more effective and less invasive alternative to traditional IVF.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI

Business Model

B2B2C

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

in vitro gametogenesisIVGlab-grown eggsin vitro oogenesisinfertility treatmentIVF alternativefertility technologysynthetic ovaries3D ovarian organoidsinduced pluripotent stem cellsiPSCseggs from skin cellsreproductive technologyAI for biologycomputational biologyfertility preservation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ovelle Bio Corp. Comparables

Compare Ovelle Bio Corp. with similar companies based on industry and business-model similarity.

Ovelle Bio Corp. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ivy Natal
92%
Vitra Labs
88%
Dioseve Inc.
85%

Ovelle Bio Corp. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 10, 2026
GrantSep 1, 2025

Key People

Founding team and executive leadership

Travis Potter

Co-Founder, CEO

Founding Team

Ovelle Bio Corp. Investors

Notable investors and investment history

Ovelle Bio Corp. investors
InvestorRounds
Survival and Flourishing FundGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 6, 86% of headcount.

  • Jun 10, 2026

    $7M round raised.

Ovelle Bio Corp. Filings

Explore SEC and related filing metadata, where available.

Ovelle Bio Corp. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ovelle Bio Corp.'s valuation, stock price, and market status.

Is Ovelle Bio Corp. a public or private company?

Ovelle Bio Corp. is a private company.

What is the current stock price of Ovelle Bio Corp.?

Ovelle Bio Corp. is a private company with no public stock price. No recent secondary market data is available.

How much is Ovelle Bio Corp. worth (valuation)?

Valuation information for Ovelle Bio Corp. is not publicly available.

Can I buy Ovelle Bio Corp. stock?

Ovelle Bio Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ovelle Bio Corp.'s last funding round?

Ovelle Bio Corp.'s most recent funding round was Seed Round on June 10, 2026.

Who are the main investors in Ovelle Bio Corp.?

Investor information for Ovelle Bio Corp. is not publicly disclosed.

Will Ovelle Bio Corp. IPO soon?

No public IPO plans have been announced for Ovelle Bio Corp..

How can I track Ovelle Bio Corp. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ovelle Bio Corp.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range7
Year Founded2024
Last FundingJun 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?